Literature DB >> 7814564

First report of involvement of Nodulisporium species in human disease.

G M Cox1, W A Schell, R L Scher, J R Perfect.   

Abstract

Allergic fungal sinusitis is a common disease that results from a hypersensitivity reaction mounted by the host against fungi living in the paranasal sinuses. We have recently treated a patient with allergic fungal sinusitis due to a Nodulisporium species. This is the first description of a Nodulisporium species involved in human disease. The genus Nodulisporium contains both dematiaceous and nondematiaceous members. These fungi occur worldwide in nature, often as accompanying conidial anamorphs of certain wood decay ascomycetes. Clinical mycology laboratories may encounter this new agent of phaeohyphomycosis.

Entities:  

Mesh:

Year:  1994        PMID: 7814564      PMCID: PMC263989          DOI: 10.1128/jcm.32.9.2301-2304.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

Review 1.  The role of allergy in sinusitis in adults.

Authors:  S L Spector
Journal:  J Allergy Clin Immunol       Date:  1992-09       Impact factor: 10.793

2.  Allergic fungal sinusitis. Report of three cases associated with dematiaceous fungi.

Authors:  G C Friedman; R W Hartwick; J Y Ro; G Y Saleh; J J Tarrand; A G Ayala
Journal:  Am J Clin Pathol       Date:  1991-09       Impact factor: 2.493

3.  Allergic fungal sinusitis: problems in diagnosis and treatment.

Authors:  A L Allphin; M Strauss; F W Abdul-Karim
Journal:  Laryngoscope       Date:  1991-08       Impact factor: 3.325

  3 in total
  2 in total

1.  Isolation of a Nodulisporium species from a case of cerebral phaeohyphomycosis.

Authors:  P Umabala; V Lakshmi; A R Murthy; V S Prasad; C Sundaram; H Beguin
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 2.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.